October 10, 2005
Neurion Pharmaceuticals, Inc. Scientific Advisor Robert H. Grubbs Wins 2005 Nobel Prize in Chemistry

June 2, 2005
Neurion Pharmaceuticals, Inc. Wins $500,000 NIMH SBIR Grant to Develop New Drugs for Anxiety

September 20, 2004
Neurion Pharmaceuticals, Inc. Appoints Paul B. Bennett, Ph.D., as Vice President, Discovery

January 8, 2004
Neurion Pharmaceuticals, Inc. Renews and Expands Collaboration on HERG Ion Channel and Drug Development with Pfizer Inc.

July 8, 2003
Neurion Pharmaceuticals, Inc., Announces CNS Drug Discovery Alliance with Eli Lilly and Company

March 12, 2003
Neurion Pharmaceuticals, Inc., Appoints Michael C. Sanguinetti, Professor of Physiology at the Univ. Utah and an Expert in Ion Channel Pharmacology, to its Scientific Advisory Board

January 15, 2003
Neurion Pharmaceuticals, Inc., Signs Research Agreement with Pfizer Inc. to Model Drug Interactions with the HERG Ion Channel, a Well-Known Source of Drug Toxicity

July 10, 2002
Neurion Pharmaceuticals, Inc., Appoints Steven E. Hyman, M.D., Provost of Harvard University and Past Director of the National Institute of Mental Health, to its Scientific Advisory Board

July 10, 2002
Neurion Pharmaceuticals, Inc., Appoints Kendall N. Houk, Ph.D., Professor of Chemistry at UCLA, to its Scientific Advisory Board

July 10, 2002
Neurion Pharmaceuticals, Inc., Appoints Robert H. Grubbs, Ph.D., Atkins Professor of Chemistry at Caltech, to its Scientific Advisory Board

January 31, 2002
Neurion Pharmaceuticals, Inc., Receives Seed Investment from Convergent Ventures, of Los Angeles